Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / China

Peptide legality · China · updated 2026-09-22

Are peptides legal in China?

Restricted

Peptides are legal in China only as NMPA-approved prescription medicines (such as semaglutide, insulin and human growth hormone); unapproved 'research' peptides like BPC-157 and TB-500 have no marketing authorization and cannot be lawfully manufactured, sold or dispensed for human use in China.

Legal status overview

Peptides are restricted in China: they are lawful only when they are medicines approved and registered by the National Medical Products Administration (NMPA) and are then sold as prescription drugs. China regulates drugs under a national registration and prescription/OTC classification system, so approved peptide drugs (e.g. GLP-1 semaglutide, somatropin/HGH) require a doctor's prescription, while peptides with no NMPA approval cannot be legally marketed for human use. Personal importation of medicines is limited to reasonable personal-use quantities and generally requires a prescription or proof of medical need.

Key points

  • The National Medical Products Administration (NMPA) is China's national drug regulator responsible for registering, approving and supervising all medicines, including peptide drugs. [1]
  • In China only drugs registered and approved by the NMPA may be legally manufactured and marketed, so peptides without NMPA marketing authorization cannot be lawfully sold for human use. [2]
  • China approved the GLP-1 peptide semaglutide (Wegovy®) through the NMPA in June 2024 for long-term weight management, making it a lawful prescription medicine rather than a research chemical. [3]
  • NMPA-approved peptide medicines in China are dispensed as prescription drugs and require a physician's prescription, not over-the-counter sale. [4]
  • Travelers may bring medicines into China only in reasonable quantities for personal use, and prescription medicines should be accompanied by a doctor's prescription or medical documentation. [5]
  • Controlled psychotropic and narcotic medications require special documentation and prior approval to bring into China, reflecting China's strict import controls on regulated pharmaceuticals. [6]
  • No China-specific statute naming research peptides such as BPC-157 or TB-500 was located; their status is inferred from the general rule that any drug lacking NMPA approval cannot be lawfully marketed, so this reflects the general framework rather than a peptide-specific law. (no source found)

Compound-by-compound status

BPC-157BPC-157 is not an NMPA-approved drug in China and has no marketing authorization, so it cannot be lawfully sold or dispensed for human use and exists only as an unapproved research chemical. (no source found)
Semaglutide (GLP-1, weight-loss/diabetes)Semaglutide is legal in China as an NMPA-approved prescription medicine, with Wegovy® cleared in June 2024 for long-term weight management and semaglutide already approved for type 2 diabetes. [3]
TB-500 (thymosin beta-4 fragment)TB-500 has no NMPA marketing authorization in China and cannot be lawfully sold or prescribed for human use, remaining an unapproved research chemical. (no source found)
Human growth hormone (HGH / somatropin)Recombinant human growth hormone (somatropin) is available in China only as an NMPA-approved prescription medicine and cannot be obtained lawfully without a physician's prescription. (no source found)

Frequently asked questions

Can I buy peptides in China without a prescription?

No. In China, approved peptide medicines such as semaglutide and human growth hormone are prescription-only drugs regulated by the NMPA, and peptides without NMPA approval cannot be sold for human use at all. [4]

Can I bring peptides into China for personal use?

Only in limited circumstances: China permits travelers to carry medicines in reasonable quantities for personal use, and prescription medicines should be supported by a doctor's prescription, while unapproved peptides and controlled substances risk seizure. [5]

Is semaglutide (Wegovy®/Ozempic®) legal in China?

Yes. Semaglutide is legal in China as an NMPA-approved prescription drug, with Wegovy® approved in June 2024 for weight management, so it must be obtained through a licensed prescription. [3]

Is BPC-157 legal in China?

No approved status exists: BPC-157 has no NMPA marketing authorization in China, so it cannot be lawfully manufactured, sold or dispensed for human use and is treated as an unapproved substance. [2]

How can I legally obtain peptides in China?

The only lawful route in China is to receive an NMPA-approved peptide medicine (such as semaglutide or somatropin) via a prescription from a licensed physician and dispensed by a licensed pharmacy or hospital. [4]

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in China, consult a licensed attorney or the national regulator.